Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Scientific Reports
|
December 9, 2016
Inhibition of PKR protects against H<sub>2</sub>O<sub>2</sub>-induced injury on neonatal cardiac myocytes by attenuating apoptosis and inflammation
Yongyi Wang, Min Men, Bo Xie, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 6, 2010
Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats
Cheng Liu, Qing Tao, Mingyu Sun, et al.
Scientific Reports
|
January 11, 2017
Plasma Amino Acid Profile in Patients with Aortic Dissection
Linlin Wang, Sha Liu, Wengang Yang, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
ACH-806, an NS4A antagonist, inhibits hepatitis C virus replication by altering the composition of viral replication complexes
Wengang Yang, Yongnian Sun, Xiaohong Hou, et al.
ACS Applied Materials & Interfaces
|
June 6, 2023
Nanoparticle-dsRNA Treatment of Pollen and Root Systems of Diseased Plants Effectively Reduces the Rate of Tobacco Mosaic Virus in Contemporary Seeds
Xiang Xu, Yubing Jiao, Lili Shen, et al.
Cancer Medicine
|
September 16, 2024
Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non-small cell lung cancer
Xiaxia Chen, Wei Zhang, Lan Luo, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2010
Discovery of novel 1-phenyl-cycloalkane carbamides as potent and selective influenza fusion inhibitors
Guozhi Tang, Zongxing Qiu, Xianfeng Lin, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2018
Ferrocene-based inhibitors of hepatitis C virus replication that target NS5A with low picomolar in vitro antiviral activity
Venkat R Gadhachanda, Kyle J Eastman, Qiuping Wang, et al.
Anti-Cancer Drugs
|
February 2, 2023
Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer
Mengfan Wang, Zhu Ma, Qingsong Li, et al.
Anti-Cancer Drugs
|
November 30, 2018
Pemetrexed plus cisplatin versus docetaxel plus cisplatin for stage IV lung adenocarcinoma based on propensity score matching
ShengFa Su, LingFeng Liu, YiChao Geng, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Scientific Reports
|
December 9, 2016
Inhibition of PKR protects against H<sub>2</sub>O<sub>2</sub>-induced injury on neonatal cardiac myocytes by attenuating apoptosis and inflammation
Yongyi Wang, Min Men, Bo Xie, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 6, 2010
Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats
Cheng Liu, Qing Tao, Mingyu Sun, et al.
Scientific Reports
|
January 11, 2017
Plasma Amino Acid Profile in Patients with Aortic Dissection
Linlin Wang, Sha Liu, Wengang Yang, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
ACH-806, an NS4A antagonist, inhibits hepatitis C virus replication by altering the composition of viral replication complexes
Wengang Yang, Yongnian Sun, Xiaohong Hou, et al.
ACS Applied Materials & Interfaces
|
June 6, 2023
Nanoparticle-dsRNA Treatment of Pollen and Root Systems of Diseased Plants Effectively Reduces the Rate of Tobacco Mosaic Virus in Contemporary Seeds
Xiang Xu, Yubing Jiao, Lili Shen, et al.
Cancer Medicine
|
September 16, 2024
Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non-small cell lung cancer
Xiaxia Chen, Wei Zhang, Lan Luo, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 25, 2010
Discovery of novel 1-phenyl-cycloalkane carbamides as potent and selective influenza fusion inhibitors
Guozhi Tang, Zongxing Qiu, Xianfeng Lin, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2018
Ferrocene-based inhibitors of hepatitis C virus replication that target NS5A with low picomolar in vitro antiviral activity
Venkat R Gadhachanda, Kyle J Eastman, Qiuping Wang, et al.
Anti-Cancer Drugs
|
February 2, 2023
Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer
Mengfan Wang, Zhu Ma, Qingsong Li, et al.
Anti-Cancer Drugs
|
November 30, 2018
Pemetrexed plus cisplatin versus docetaxel plus cisplatin for stage IV lung adenocarcinoma based on propensity score matching
ShengFa Su, LingFeng Liu, YiChao Geng, et al.
Page
of 5